About Maximon Pharma Private Limited
Data last updated:
Maximon Pharma Private Limited is a private limited company based in New, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 12 June 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74900DL2018PTC335210. Its GSTIN is 07AALCM9162F1Z6 (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Sarita Kapur and Harshavardhan Karunakar Hegde.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No. 512 And 513 Fifth Floor Plot No. 6, Pragati Devika Tower Nehru Place South Delhi – 110019, New, Delhi, India – 110019.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.55 Cr, a growth of 30% compared to the previous year. For the same year it recorded a net profit of ₹18.45 Lakh (net margin 11.9%) and EBITDA of ₹12.13 Lakh (EBITDA margin 7.8%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years and 18% over five years.
The company has about 8 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Maximon Pharma.
For more details, the company can be reached via its website maximonwellness.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressNo. 512 And 513 Fifth Floor Plot No. 6, Pragati Devika Tower Nehru Place South Delhi – 110019, New, Delhi, India – 110019
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Associated Brands with Maximon Pharma Private Limited
Maximon Pharma operates one associated brand: Maximon Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Supplies and exports pharmaceutical products, medicines, and health supplements globally. | maximonwellness.com |
Competitors & Alternatives of Maximon Pharma Private Limited
Brands and companies operating in the same space as Maximon Pharma Private Limited include Pfizer, Entero Healthcare, AmerisourceBergen and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
 Pfizer | Pharmaceutical products for treating multiple diseases are provided. | New York, United States | 1849 |
 Entero Healthcare | India's leading healthcare products distribution platform | Mumbai, India | 2018 |
 AmerisourceBergen | Pharmaceutical distribution and supply chain services are provided globally. | Chesterbrook, United States | 1985 |
 Keimed | Temperature-sensitive medicines are distributed via cold chain logistics by Keimed. | Hyderabad, India | 2000 |
 EBOS Group | Wholesaler & distributor of healthcare, medical, and pharmaceutical products | Docklands, Australia | 1922 |
 Target Healthcare | Distributor of pharmaceutical products | East Kilbride, United Kingdom | 2012 |
 CHEPLAPHARM | Branded pharmaceutical products are developed, marketed, and distributed globally. | Mesekenhagen, Germany | 1998 |
 Sandor Medicaids | Provider of medical equipment, devices, and drugs distribution services | Hyderabad, India | 1995 |
 NEUCA | Wholesale distribution of pharmaceuticals is managed by NEUCA in Poland. | Torun, Poland | 1990 |
 Renee | Diversified drugs are distributed by Renee in the United States. | Los Angeles, United States | 2021 |
Business Activity of Maximon Pharma Private Limited
The main business activity of Maximon Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Maximon Pharma Private Limited
Maximon Pharma Private Limited is audited by KUMAR VERMA & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| KUMAR VERMA & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Maximon Pharma Private Limited
Maximon Pharma has 6 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sarita Kapur Also directs: Rico Auto Industries Limited, SMC Global Securities Limited | Director | 01 Aug 2021 | 5 Years 2 Months | Current |
| Harshavardhan Karunakar Hegde Also directs: Team Ortho Private Limited, Nutralodge Private Limited, Labnow Solutions Private Limited and 2 more | Director | 12 Jun 2018 | 8 Years 3 Months | Current |
| Akshay Kumar Saxena Also directs: Nutralodge Private Limited, Universal Critical Care LLP | Director | 12 Jun 2018 | 8 Years 3 Months | Current |
| Anjali Harshavardhan Hegde Also directs: Team Ortho Private Limited | Director | 01 Aug 2021 | 5 Years 2 Months | Current |
| Rakesh Mattoo Also directs: Nutralodge Private Limited | Director | 12 Jun 2018 | 8 Years 3 Months | Current |
| Arundhati Hegde Also directs: Iomprecision International LLP | Director | 01 Aug 2021 | 5 Years 2 Months | Current |
Financials of Maximon Pharma Private Limited FY 2025 filings available
Maximon Pharma Private Limited reported revenue of ₹1.55 Cr (up 30% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Maximon Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 18% over five years, including 30% growth in the latest year. EBITDA rose 118% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Maximon Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹12.13 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹18.45 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Maximon Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 11.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Maximon Pharma are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Maximon Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Maximon Pharma Private Limited
Maximon Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Maximon Pharma Private Limited
Maximon Pharma Private Limited has a workforce of 8 employees as of Apr 02, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Maximon Pharma Private Limited
Maximon Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AALCM9162F1Z6 | Delhi | Active | 16 Apr 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Maximon Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Maximon Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Maximon Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Maximon Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Maximon Pharma Private Limited
Recent News on Maximon Pharma Private Limited
Frequently Asked Questions about Maximon Pharma Private Limited
Maximon Pharma is an active private limited company based in New, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 12 June 2018 (8+ years old) and is registered under CIN U74900DL2018PTC335210.
Maximon Pharma reported revenue of ₹1.55 Cr for FY 2025 (up 30% YoY).
Maximon Pharma has 6 current directors:
- Sarita Kapur - Director
- Harshavardhan Karunakar Hegde - Director
- Akshay Kumar Saxena - Director
- Anjali Harshavardhan Hegde - Director
- Rakesh Mattoo - Director
- Arundhati Hegde - Director
Maximon Pharma reported a net profit of ₹18.45 Lakh (net margin 11.9%) and EBITDA of ₹12.13 Lakh (EBITDA margin 7.8%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Maximon Pharma is -11% over three years and 18% over five years. In the latest year (FY 2025) revenue rose 30%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Maximon Pharma is 07AALCM9162F1Z6, registered in Delhi.
The CIN (Corporate Identification Number) of Maximon Pharma is U74900DL2018PTC335210. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Maximon Pharma was incorporated on 12 June 2018, making it 8+ years old. It is registered with the Registrar of Companies, Delhi.
Maximon Pharma can be reached through the website maximonwellness.com. Its registered office is in New, Delhi, India.